FDA Authorizes  Pfizer Covid-19 Vaccine for Children 5-11

The FDA has authorized Pfizer’s COVID-19 vaccine for children ages 5 to 11. The children’s dose is one-third (10mcg) of that given to teens and adults and would be administered in two doses, three weeks apart. Vaccination for this age group is anticipated to begin as early as next week. Moderna said last week that a low dose of its vaccine is effective in children 6-11 and could be available in a few weeks. However, the company is yet to submit its data to the FDA for review.